Microport EP Medtech

Explore the latest insights on Microport EP Medtech and its impact on China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data, news, and intelligence to help you navigate the complexities of Microport EP Medtech’s developments with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Fineline Info & Tech (Flcube.com) provides you with comprehensive information about Microport EP Medtech, including details on the company, its pharmaceuticals, policies, deals, healthcare enterprises, research and development, hospitals, legal patents, and internet healthcare. More information about Microport EP Medtech please access flcube.com

Biokin Scores Triple NMPA Breakthrough Therapy Designation – BL-M07D1, BL-M05D1, and Iza‑Bren Recognized Across Biliary Tract and Gastric Cancers
CompanyDrug

Biokin Scores Triple NMPA Breakthrough Therapy Designation – BL-M07D1, BL-M05D1, and Iza‑Bren Recognized Across Biliary Tract and Gastric Cancers

Sichuan Biokin Pharmaceutical Co., Ltd. (SHA: 688506) announced that its three drug candidates – BL-M07D1, BL-M05D1, and izalontamab bretecan – have been granted Breakthrough Therapy Designation (BTD) by the Center…

Biokin's BL-M12D1 Wins NMPA Clinical Trial Approval – ADC Candidate to Be Evaluated as Monotherapy in Relapsed or Refractory Hematologic Malignancies

Biokin’s BL-M12D1 Wins NMPA Clinical Trial Approval – ADC Candidate to Be Evaluated as Monotherapy in Relapsed or Refractory Hematologic Malignancies

Haisco's HSK42360-Na Granted NMPA Breakthrough Therapy Designation – BRAF Paradoxical Breaker Targets High‑Grade Glioma with BRAF V600 Mutation

Haisco’s HSK42360-Na Granted NMPA Breakthrough Therapy Designation – BRAF Paradoxical Breaker Targets High‑Grade Glioma with BRAF V600 Mutation

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyMedical Device

Microport EP Medtech’s EasyEcho ICE Catheter Wins NMPA Market Clearance

Microport's PulseMagic PFA-Catheter Secures NMPA Approval as First Pressure-Monitoring Device in China
CompanyMedical Device

Microport’s PulseMagic PFA-Catheter Secures NMPA Approval as First Pressure-Monitoring Device in China

Shanghai MicroPort EP MedTech's IceMagic Catheter Receives EU MDR Certification
CompanyMedical Device

Shanghai MicroPort EP MedTech’s IceMagic Catheter Receives EU MDR Certification

Shanghai Microport EP Medtech Secures NMPA Fast-Track Designation for EasyEcho Catheter
CompanyMedical Device

Shanghai Microport EP Medtech Secures NMPA Fast-Track Designation for EasyEcho Catheter

Stereotaxis and MicroPort EP Receive NMPA Approval for Magbot Magnetic Navigation Ablation Catheter
CompanyMedical Device

Stereotaxis and MicroPort EP Receive NMPA Approval for Magbot Magnetic Navigation Ablation Catheter

Genesis RMN Robotic Magnetic Navigation System Approved by China's NMPA
CompanyMedical Device

Genesis RMN Robotic Magnetic Navigation System Approved by China’s NMPA

CompanyMedical Device

Microport EP Medtech’s Cryoablation Catheter and Equipment Approved as Innovative Devices in China

CompanyDeals

MicroPort Scientific Plans IPO for Subsidiary MicroPort CRM on Hong Kong Stock Exchange

Show More